Sir: Serotonin reuptake inhibitors (SRIs) and venlafaxine continue to play a prominent role in the treatment of depression. Utilization of these agents, however, has been complicated by the now well-described serotonin discontinuation syndrome.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
This PDF is free for all visitors!